# Effect of Tenofovir Disoproxil Fumarate on Lipid Levels in HIV Infected Adults on Stable Anti-HIV Drug Therapy

> **NCT00109603** · NA · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 17 (actual)

## Conditions studied

- HIV Infections
- Dyslipidemia
- Hyperlipidemia
- Hypercholesterolemia
- Hypertriglyceridemia

## Interventions

- **DRUG:** Tenofovir disoproxil fumarate

## Key facts

- **NCT ID:** NCT00109603
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-05
- **Primary completion:** 2007-07
- **Final completion:** 2007-11
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2012-10-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00109603

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00109603, "Effect of Tenofovir Disoproxil Fumarate on Lipid Levels in HIV Infected Adults on Stable Anti-HIV Drug Therapy". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00109603. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*